Skip to content

Impact of a Low Carbohydrate Breakfast on Glucose Control in Type 2 Diabetes

Impact of a Low Carbohydrate Breakfast on Glucose Control in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02982330
Enrollment
27
Registered
2016-12-05
Start date
2016-11-30
Completion date
2017-08-31
Last updated
2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes

Brief summary

Large glucose excursions at breakfast are prevalent in type 2 diabetes and can contribute to sustained hyperglycaemia across the day. Lowering consumption of dietary carbohydrate is known to reduce post-meal glucose excursions but it is unknown whether lowering the carbohydrate at breakfast only will impact subsequent post meal glucose excursions throughout the day. The aim of this study is to examine, under free living conditions and using typical dietary patterns, whether eating a breakfast low in carbohydrate can lower daily post-meal glycemia when compared to consuming a low-fat breakfast (per the current diabetes guidelines).

Interventions

BEHAVIORALLow Carbohydrate Breakfast

A low carbohydrate breakfast containing \<10% carbohydrate, \ 75% fat, and 15% protein. Matched for calories to the active comparator arm.

BEHAVIORALGuidelines Breakfast

A low fat breakfast containing \ 55% carbohydrate, \<30% fat, and 15% protein. Matched for calories to the experimental arm.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Physician-diagnosed Type 2 Diabetes (\>6 months)

Exclusion criteria

* Exogenous Insulin * A1c \> 9% * Cardiovascular, liver, or renal other disease * Breakfast and meal skippers

Design outcomes

Primary

MeasureTime frame
Incremental area under the glucose curve (continuous glucose monitor)24 hour (one day)

Secondary

MeasureTime frame
Mean Blod Glucose (continuous glucose monitor)24 hours (one day)

Other

MeasureTime frame
Glycemic Variability (continuous glucose monitor)24 hours (one day)
Satiety VAS 100Before and after meals (one day)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026